Lidia Fonseca - Feb 23, 2023 Form 4 Insider Report for PFIZER INC (PFE)

Role
Executive Vice President
Signature
Susan E. Grant, by power of atty., for Lidia Fonseca
Stock symbol
PFE
Transactions as of
Feb 23, 2023
Transactions value $
$0
Form type
4
Date filed
2/24/2023, 07:22 PM
Previous filing
Jun 30, 2022
Next filing
May 3, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PFE Common Stock 35.8K Feb 23, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Award $0 +43.6K $0.00 43.6K Feb 23, 2023 Common Stock 43.6K $42.30 Direct F1
transaction PFE Stock Appreciation Rights Award $0 +38K $0.00 38K Feb 23, 2023 Common Stock 38K $42.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F2 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.